Kavimun tablets are used in combination with other antiretroviral medications for the treatment of Human Immunodeficiency Virus (HIV-1) infection[1]. They are not intended to cure HIV, but help to suppress the virus and slow the progression of the disease by inhibiting HIV replication in the body[1].
The active pharmaceutical ingredients in Kavimun tablets are abacavir and lamivudine, both of which are commonly used as part of HIV therapy[2]. This combination helps to lower the amount of HIV in your body, thereby supporting the immune system and delaying the onset of HIV-related complications[2]. Kavimun (abacavir/lamivudine) is typically administered once daily as part of a regimen tailored to each patient’s clinical needs[4].
Kavimun and similar tablet combinations are recommended for:
- Adults, adolescents, and children (weighing at least 25 kg) diagnosed with HIV-1 infection, as part of antiretroviral combination therapy[1].
- Younger children or patients with specific considerations may have dosing adjusted by weight and age[4].
It is important that therapy is prescribed by a physician experienced in managing HIV infection. Regular monitoring is required due to potential side effects (such as hypersensitivity or allergic reactions) and possible interactions with other medicines[1].
Leave a Reply